Effect of α1-Adrenergic Antagonists on Lower Ureteral Stones With Extracorporeal Shock Wave Lithotripsy

Asian Journal of Surgery

Volumn 33, Issue 1, 2010, Pages 37-41

  Wang, Huijun ^a   Liu, Ke ^a   Ji, Zhigang ^a   Li, Hanzhong ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

1 adrenergic antagonists; lithotripsy; lower ureteral stone

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; SULFONAMIDE; TAMSULOSIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; LITHOTRIPSY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; URETER STONE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; SULFONAMIDES; TREATMENT OUTCOME; URETERAL CALCULI; YOUNG ADULT;

EID: 77953168836     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/S1015-9584(10)60007-3     Document Type: Article

References (15)

1. Dellabella M., Milanese G., and Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170 (2003) 2202-2205
2. Dellabella M., Milanese G., and Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureter calculi. J Urol 174 (2005) 167-172
3. Malin Jr. J.M., Deane R.F., and Boyarsky S. Characterization of adrenergic receptors in human ureter. Br J Urol 42 (1970) 171-174
4. Menon M., and Resnick M.I. Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh P.C. (Ed). Campbell's Urology (2002), Saunders, Philadelphia 3227-3229
5. Stoller M.L., and Bolton D.M. Urinary stone disease. In: Tanagho E.A. (Ed). Smith's Urology (2000), Lange Medical Book/McGraw-Hill, San Francisco 292-320
6. Miyatake R., Tomiyama Y., Murakami M., et al. Effects of isoproterenol and butylscopolamine on the friction between an artificial stone and the intraureteral wall in anesthetized rabbits. J Urol 166 (2001) 1083-1087
7. Weiss R.M. Physiology and pharmacology of renal pelvis and ureter. In: Walsh P.C. (Ed). Campbell's Urology (2002), Saunders, Philadelphia 377-456
8. Hancock A.A. α1 adrenoceptor: a synopsis of their pharmacology and molecular biology. Drug Dev Des 39 (1996) 54-107
9. Sigala S., Dellabella M., Milanese G., et al. Alpha1 adrenoceptor subtypes in men juxtavesical ureter: molecular and pharmacological characterization. Eur Urol 3 Suppl (2004) 119-122
10. Hieble J.P., Caine M., and Zalaznik E. In vitro characterization of the alpha-adrenoceptors in human prostate. Eur J Pharmacol 107 (1985) 111-117
11. Porpiglia F., Ghignone G., Fiori C., et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172 (2004) 568-571
12. Resim S., Ekerbicer H., and Ciftci A. Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus. Int J Urol 12 (2005) 615-620
13. Küpeli B., Irkilata L., Gürocak S., et al. Does tamsulosin enhance lower stone clearance with or without shock wave lithotripsy?. Urology 64 (2004) 1111-1115
14. Porpiglia F., Destefanis P., Fiori C., et al. Role of adjunctive medical therapy with nifedipine and deflazacort after shock wave lithotripsy of ureteral stones. Urology 59 (2002) 835-838
15. Shokeir A.A. Renal colic: path physiology, diagnosis and treatment. Euro Urol 9 (2001) 241-249